QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 专题：吉林大学白求恩第一医院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A diagnostic microdosing approach to investigate platinum sensitivity in non-small cell lung cancer 期刊论文 INTERNATIONAL JOURNAL OF CANCER, 2017, 卷号: 141, 期号: 3 作者:  Zimmermann, Maike;  Zhang, Hongyong;  Lin, Tzu-yin;  Malfatti, Michael;  Wang, Si-Si 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 non-small cell lung cancer  platinum-based chemotherapy  diagnostic  microdosing  predictive diagnostics  accelerator mass spectrometry  biomarkers of response   Vitamin D deficiency is associated with a poor prognosis in advanced non-small cell lung cancer patients treated with platinum-based first-line chemotherapy 期刊论文 CANCER BIOMARKERS, 2017, 卷号: 18, 期号: 3 作者:  Ma, Kewei;  Xu, Wang;  Wang, Chang;  Li, Biao;  Su, Keju 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Non-small cell lung cancer  advanced  platinum-based first-line chemotherapy  25(OH) D  survival  prognostic factor   High glasgow prognostic score associates with a poor survival in Chinese advanced non-small cell lung cancer patients treated with platinum-based first-line chemotherapy 期刊论文 INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 卷号: 9, 期号: 8 作者:  Su, Keju;  Wang, Xu;  Chi, Lumei;  Liu, Yang;  Jin, Lina 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Non-small cell lung cancer  glasgow prognostic score  prognosis  overall survival  progression-free survival   Afatinib (A) vs erlotinib (E) as second-line therapy of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following platinum-based chemotherapy: Overall survival (OS) analysis from the global phase III trial LUX-Lung 8 (LL8). 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2015, 卷号: 33, 期号: 15 作者:  Soria, Jean-Charles;  Felip, Enriqueta;  Cobo, Manuel;  Lu, Shun;  Syrigos, Konstantinos N. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following first-line platinum-based chemotherapy: Patient-reported outcome (PRO) data from the LUX-Lung 8 Phase III global trial. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2015, 卷号: 33, 期号: 15 作者:  Gadgeel, Shirish M.;  Dols, Manuel Cobo;  Felip, Enriqueta;  Soria, Jean-Charles;  Lee, Ki Hyeong 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 LUX-Lung 8: A Global Phase III Trial of Afatinib (A) vs Erlotinib (E) as Second-Line Treatment in Patients (Pts) With Advanced Squamous Cell Carcinoma (SCC) of the Lung Following First-Line Platinum-Based Chemotherapy 会议论文 作者:  Hirsh, Vera;  Gadgeel, Shirish;  Soria, Jean-Charles;  Felip, Enriqueta;  Cobo, Manuel 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following first-line platinum-based chemotherapy: Patient-reported outcome (PRO) data from the LUX-Lung 8 Phase III global trial. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2015, 卷号: 33, 期号: 15 作者:  Gadgeel, Shirish M.;  Dols, Manuel Cobo;  Felip, Enriqueta;  Soria, Jean-Charles;  Lee, Ki Hyeong 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05